...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM

Fouremm, 

Thanks for attending both AGMs and reporting some of your notes on both. Also, great question about GS-5892.

BearDownAZ 

Share
New Message
Please login to post a reply